Archive for KalVista

KalVista Pharmaceuticals to Present Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology

November 2, 2023

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

October 16, 2020

KalVista Pharmaceuticals Reports First Fiscal Quarter Results

September 15, 2020

KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results

July 8, 2020

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

January 13, 2020

KalVista Provides Business Update; Phase 2 Clinical Trial in HAE Expected to Complete Enrollment in 2019 with Data in 2020; Phase 2 Clinical Trial Data in DME Expected This Quarter

November 14, 2019